Retroviral vectors for production of interleukin-12 in the bone marrow to induce a graft-versus-leukemia effect

Annals of the New York Academy of Sciences

Volumn 795, Issue , 1996, Pages 341-345

  Hawley, Robert G ^a,b   Lieu, Francis H L ^a,b   Fong, Andrew Z C ^a,b   Goldman, Samuel J ^c   Leonard, John P ^c   Hawley, Teresa S ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12;

ANIMAL CELL; BONE MARROW; CONFERENCE PAPER; CONTROLLED STUDY; EXPRESSION VECTOR; GENETIC TRANSDUCTION; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; LEUKEMIA; MOUSE; NONHUMAN; RETROVIRUS; STEM CELL TRANSPLANTATION; VIRUS RECOMBINANT;

EID: 0030448052     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb52687.x     Document Type: Conference Paper

References (24)

1. BEATTY, P. G. 1995. Bone marrow transplantation for the treatment of hematologic diseases: Status in 1994. Exp. Hematol. 23: 277-288.
2. RIZZOLI, V. & C. CARLO-STELLA. 1995. Stem cell purging: an intriguing dilemma. Exp. Hematol. 23: 296-302.
3. ANTIN, J. H. 1993. Graft-versus-leukemia: No longer an epiphenomenon. Blood 82: 2273-2277.
4. CHAMPLIN, R. 1995. Separation of graft-vs.-host disease and graft-vs.leukemia effect against chronic myelogenous leukemia. Exp. Hematol. 23: 1148-1151.
5. BlLGRAMI, S., M. SlLVA, A. CARDOSO, K. B. MILLER & J. L. ASCENSAO. 1994. Immunotherapy with autologous bone-marrow transplantation: rationale and results. Exp. Hematol. 22: 1039-1050.
6. BRUNDA, M. J., L. LUISTRO, R. R. WARRIER, R. B. WRIGHT, B. R. HUBBARD, M. MURPHY, S. F. WOLF & M. K. GATELY. 1993. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med. 178: 1223-1230.
7. TAHARA, H. & M. T. LOTZE. 1995. Antitumor effects of interleukin-12 (IL-12): Applications for the immunotherapy and gene therapy of cancer. Gene Ther. 2: 96-106.
8. JACOBSEN, S. E. W., O. P. VEIBY & E. B. SMELAND. 1993. Cytotoxic lymphocyte maturation factor (interleukin 12) is a synergistic growth factor for hematopoietic stem cells. J. Exp. Med. 178: 413-418.
9. SYKES, M., G. L. SZOT, P. L. NGUYEN & D. A. PEARSON. 1995. Interleukin-12 inhibits murine graft-versus-host disease. Blood 86: 2429-2438.
10. TRINCHIERI, G. 1995. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Ann. Rev. Immunol. 13: 251-276.
11. RUHR, T., G. J. DOUGHERTY & H.-G. KLINGEMANN. 1994. Transfer of the tumor necrosis factor α gene into hematopoietic progenitor cells as a model for site-specific cytokine delivery after marrow transplantation. Blood 84: 2966-2970.
12. HAWLEY, R. G., F. H. L. LIEU, A. Z. C. FONG & T. S. HAWLEY. 1994. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1: 136-138.
13. HAWLEY, R. G., A. Z. C. FONG, B. F. BURNS & T. S. HAWLEY. 1992. Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus. J. Exp. Med. 176: 1149-1163.
14. HAWLEY, R. G., A. Z. C. FOND, B. Y. NGAN, V. M. DE LANUX, S. C. CLARK & T. S. HAWLEY. 1993. Progenitor cell hyperplasia with rare development of myeloid leukemia in interleukin 11 bone marrow chimeras. J. Exp. Med. 178: 1175-1188.
15. HAWLEY, R. G., A. Z. C. FONG, M. LU & T. S. HAWLEY. 1994. The HOX11 homeobox-containing gene of human leukemia immortalizes murine hematopoietic precursors. Oncogene 9: 1-12.
16. HAWLEY, R. G., A. Z. C. FONG, B.-Y. NGAN & T. S. HAWLEY. 1995. Hematopoietic transforming potential of activated ras in chimeric mice. Oncogene 11: 1113-1123.
17. HAWLEY, R. G. 1994. Hematopathology of interleukin-6-type cytokines. Stem Cells 12: 155-171.
18. HAWLEY, R. G. 1996. Therapeutic potential of retroviral vectors. Trans. Sci. 17(1): 7-14.
19. HAWLEY, T. S., B. LACH, B. F. BURNS, L. T. MAY, P. B. SEHGAL & R. G. HAWLEY. 1991. Expression of retrovirally transduced IL-1α in IL-16-dependent B cells: A murine model of aggressive multiple myeloma. Growth Factors 5: 327-338.
20. CULVER, K. W., Z. RAM, S. WALLBRIDGE, H. ISHII, E. H. OLDFIELD & R. M. BLAESE. 1992. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256: 1550-1552.
21. HANTZOPOULOS, P. A., B. A. SULLENGER, G. UNGERS & E. GILBOA. 1989. Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector. Proc. Natl. Acad. Sci. USA 86: 3519-3523.
22. GHATTAS, I. R., J. R. SANES & J. E. MAJORS. 1991. The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos. Mol. Cell. Biol. 11: 5848-5859.
23. ZITVOGEL, L., H. TAHARA, Q. CAI, W. J. STORKUS, G. MULLER, S. F. WOLF, M. GATELY, P. D. ROBBINS & M. T. LOTZE. 1994. Construction and characterization of retroviral vectors expressing biologically active human interleukin-12. Hum. Gene Ther. 5: 1493-1506.
24. MARTINOTTI, A., A. STOPPACCIARO, M. VAGLIANI, C. MELANI, F. SPREAFICO, M. WYSOCKA, G. PARMIANI, G. TRINCHIERI & M. P. COLOMBO. 1995. CD4 T cells inhibit in vivo the CDS-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes. Eur. J. Immunol. 25: 137-146.